MyFinsight
Home
Blog
About
Proceeds from common
stock issued under...
$2,800K
(3.70%↑ Y/Y)
Net cash (used in)
provided by financing...
$2,200K
(-86.42%↓ Y/Y)
Effect of foreign
exchange rates on cash,...
$100K
(-85.71%↓ Y/Y)
Canceled cashflow
$600K
Net decrease in
cash, cash...
-$9,200K
(67.38%↑ Y/Y)
Canceled cashflow
$2,300K
Trade accounts
receivable
-$14,400K
(-193.51%↓ Y/Y)
Depreciation and
amortization
$12,500K
(-56.14%↓ Y/Y)
Stock-based compensation
expense
$7,200K
(-64.36%↓ Y/Y)
Prepaid expenses and
other current assets
-$2,800K
(-833.33%↓ Y/Y)
Non-cash lease expense
$1,100K
(-80.36%↓ Y/Y)
Accrued liabilities
$1,000K
(103.42%↑ Y/Y)
Other non-cash
adjustments
$700K
(133.33%↑ Y/Y)
Other assets
-$200K
(71.43%↑ Y/Y)
Prepaid taxes
-$200K
(90.48%↑ Y/Y)
Payment of tax withheld
for common stock...
$400K
(-93.10%↓ Y/Y)
Payment on finance
leases
$200K
(0.00%↑ Y/Y)
Net cash used in
operating activities
-$8,300K
(72.24%↑ Y/Y)
Net cash used in
investing activities
-$3,200K
(78.95%↑ Y/Y)
Canceled cashflow
$40,100K
Net loss
-$43,200K
(86.93%↑ Y/Y)
Capital expenditures
$2,100K
(-74.07%↓ Y/Y)
Capitalization of intangible
assets
$1,100K
(-84.51%↓ Y/Y)
something is missing
-$2,700K
Accounts payable
-$2,500K
(-169.44%↓ Y/Y)
Back
Back
Cash Flow
MYRIAD GENETICS INC (MYGN)
MYRIAD GENETICS INC (MYGN)
source: myfinsight.com